Invesco Ltd. - REPROS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Invesco Ltd. ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q2 2014$6,547,000
-0.5%
378,408
+2.0%
0.00%0.0%
Q1 2014$6,583,000
-0.5%
371,064
+2.6%
0.00%0.0%
Q4 2013$6,616,000
-41.7%
361,492
-14.6%
0.00%
-40.0%
Q3 2013$11,341,000
+2257.8%
423,175
+1523.7%
0.01%
Q2 2013$481,00026,0630.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,001,000$970,0000.21%
Allegis Investment Advisors, LLC 341,669$331,0000.19%
GENERAL AMERICAN INVESTORS CO INC 396,123$384,0000.04%
Alambic Investment Management, L.P. 114,591$111,0000.04%
Gruss Capital Management LP 600,000$582,0000.02%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 102,086$99,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 323,429$314,0000.01%
GSA CAPITAL PARTNERS LLP 27,931$27,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$3,0000.00%
Airain ltd 13,690$13,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders